UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Annals of oncology, 2016-08, Vol.27 (8), p.1612-1619

2016

Volltextzugriff (PDF)

Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age

European journal of pediatrics, 2024-02, Vol.183 (2), p.929-938

2024

Volltextzugriff (PDF)

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

BMC cancer, 2017-02, Vol.17 (1), p.141-141, Article 141

2017

Volltextzugriff (PDF)

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Annals of oncology, 2018-08, Vol.29 (8), p.1701-1709

2018

Volltextzugriff (PDF)

Toxicity and Efficacy of Thoracic Reirradiation With Split-Course Chemoradiation Therapy for the Curative Treatment of Recurrent Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E468-E469

2016

Volltextzugriff (PDF)

Prognostic Factors for Survival After Recurrence of Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E434-E434

2015

Volltextzugriff (PDF)

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

British journal of cancer, 2008-05, Vol.98 (10), p.1608-1613

2008

Volltextzugriff (PDF)

YI 01.03 Community versus Academic Oncology

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1732-S1732

Bonomi, P.

2017

Volltextzugriff (PDF)

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

British journal of cancer, 2011-12, Vol.105 (12), p.1920-1926

2011

Volltextzugriff (PDF)

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?: Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

Journal of clinical epidemiology, 2002-03, Vol.55 (3), p.285-295

2002

Volltextzugriff (PDF)

Patterns of Locoregional Failure in Stage III Non-Small Cell Lung Cancer Managed With Definitive Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S516-S516

2013

Volltextzugriff (PDF)

Primary Tumor Volume, Bulky Adenopathy, and Number (But Not Location) of Involved Nodal Stations Predict Outcome in N2-N3 NSCLC Treated With Definitive Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S655-S656

2014

Volltextzugriff (PDF)

Anamorelin for the Treatment of Cancer Anorexia-Cachexia in Advanced NSCLC Patients: Results From ROMANA 1, a Pivotal Phase 3 Study

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S3-S3

2014

Volltextzugriff (PDF)

Survival Benefit of Surgery Following Chemoradiation Therapy for Stage III NSCLC Is Dependent on Achieving Pathologic Nodal Clearance

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S22-S22

2014

Volltextzugriff (PDF)

A multi-analyte serum test for the detection of non-small cell lung cancer

British journal of cancer, 2010-10, Vol.103 (8), p.1221-1228

2010

Volltextzugriff (PDF)

Postinduction Inflammatory Status Predicts Complete Pathologic Response in Non-Small Cell Lung Cancer Patients Undergoing Induction Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S665-S665

2014

Volltextzugriff (PDF)

Survival Benefit of Surgery Following Chemoradiation Therapy for Stage III NSCLC Is Dependent on Achieving Pathologic Nodal Clearance

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S213-S213

2014

Volltextzugriff (PDF)

36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENT

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S16-S16

2013

Volltextzugriff (PDF)

LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program

Annals of oncology, 2023-10, Vol.34, p.S1335-S1335

2023

Volltextzugriff (PDF)

Patterns of Regional Failure in Stage III Non-small Cell Lung Cancer Managed With Neoadjuvant Chemoradiation Therapy and Resection

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S580-S580

2012

Volltextzugriff (PDF)

MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity: validation in ECOG trials

European journal of cancer (1990), 2004-05, Vol.40 (8), p.1193-1198

2004

Volltextzugriff (PDF)

Adrenal Stereotactic Body Radiation Therapy in the Management of Oligometastatic Lung Cancer: Patient Selection Matters

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e462-e463

2021

Volltextzugriff (PDF)

EP08.01-037 Association of Baseline NLR and BMI with Clinical Outcomes in NSCLC Patients Treated with Immunotherapy Alone Versus Chemo-Immunotherapy

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S354

2022

Volltextzugriff (PDF)

PO-1451 Neutrophil-lymphocyte ratio dynamics associated with survival after SBRT for stage I-II lung cancer

Radiotherapy and oncology, 2023-05, Vol.182, p.S1175-S1175

2023

Volltextzugriff (PDF)

Erlotinib: a new therapeutic approach for non-small cell lung cancer

Expert opinion on investigational drugs, 2003-08, Vol.12 (8), p.1395-1401

Bonomi, Philip

2003

Volltextzugriff (PDF)

1 – 25 von 1.268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.008)
Mit Volltextzugriff
(1.078)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Toxicity and Efficacy of Thoracic Reirradiation With Split-Course Chemoradiation Therapy for the Curative Treatment of Recurrent Non-Small Cell Lung Cancer

Prognostic Factors for Survival After Recurrence of Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Therapy

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

YI 01.03 Community versus Academic Oncology

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?: Results from Eastern Cooperative Oncology Group (ECOG) Study 5592

Patterns of Locoregional Failure in Stage III Non-Small Cell Lung Cancer Managed With Definitive Chemoradiation Therapy

Primary Tumor Volume, Bulky Adenopathy, and Number (But Not Location) of Involved Nodal Stations Predict Outcome in N2-N3 NSCLC Treated With Definitive Chemoradiation Therapy

Anamorelin for the Treatment of Cancer Anorexia-Cachexia in Advanced NSCLC Patients: Results From ROMANA 1, a Pivotal Phase 3 Study

Survival Benefit of Surgery Following Chemoradiation Therapy for Stage III NSCLC Is Dependent on Achieving Pathologic Nodal Clearance

A multi-analyte serum test for the detection of non-small cell lung cancer

Postinduction Inflammatory Status Predicts Complete Pathologic Response in Non-Small Cell Lung Cancer Patients Undergoing Induction Chemoradiation Therapy

Survival Benefit of Surgery Following Chemoradiation Therapy for Stage III NSCLC Is Dependent on Achieving Pathologic Nodal Clearance

36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENT

LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program

Patterns of Regional Failure in Stage III Non-small Cell Lung Cancer Managed With Neoadjuvant Chemoradiation Therapy and Resection

MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity: validation in ECOG trials

Adrenal Stereotactic Body Radiation Therapy in the Management of Oligometastatic Lung Cancer: Patient Selection Matters

EP08.01-037 Association of Baseline NLR and BMI with Clinical Outcomes in NSCLC Patients Treated with Immunotherapy Alone Versus Chemo-Immunotherapy

PO-1451 Neutrophil-lymphocyte ratio dynamics associated with survival after SBRT for stage I-II lung cancer

Erlotinib: a new therapeutic approach for non-small cell lung cancer

Suchergebnisse filtern